Exome Asset Management’s Veru VERU Stock Holding History

Exome Asset Management’s Portfolio VERU Stock Details VERU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-111,760	Closed	-$693K	–	83
2024 Q4	$740K	Buy	+111,760	New	+$829K	0.56%	48

Other funds holding VERU

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Exome Asset Management's VERU Position: Q1 2025 in Review

Exome Asset Management sold out of Veru (VERU) in Q1 2025, closing a stake of 111,760 shares — an estimated $693K sold.

Exome Asset Management first reported a position in VERU in Q4 2024 and held it in 1 quarter. The position peaked at $740K in Q4 2024. 130 funds tracked by Wall St. Rank hold VERU as of Q1 2025.

Exome Asset Management reported no remaining Veru position as of Q1 2025 after selling out during the quarter.
Exome Asset Management sold 111,760 Veru shares in Q1 2025, an estimated $693K.
Exome Asset Management first reported a position in Veru in Q4 2024 and held it in 1 quarter.
Exome Asset Management's Veru position peaked at $740K in Q4 2024.
130 funds tracked by Wall St. Rank held Veru as of Q1 2025.

Based on Exome Asset Management's 13F filing for Q1 2025, filed 15 May 2025.